In my opening remarks I provided a number of examples of such measures that exist, but in all markets we have a number of issues that we're trying to address. Let me add to the list that I provided in my opening remarks.
In China, we are concerned by the regulatory approval process for genetically modified products. It is very complex. The timelines seem to continually increase. Currently it can take up to 40 months to get a new GM product approved in China. Of course, as I mentioned in my opening remarks, such delays in the regulatory approval of genetically modified products are an impediment on our farmers being able to use the latest innovations in GM products. That's one illustration.
Another illustration is Korea. Our sentiment and the sentiment of the industry is that often pressures from consumer groups or industry seem to have an influence on the decision-making processes in terms of regulations. As a result, the approval process for new products or new techniques—sanitary or phytosanitary measures—lacks predictability. If we don't have predictability in trade, it can interfere very effectively with the ability of our exporters to export.
These are two illustrations of the types of measures that exist and that we are monitoring. We're working with the industry, using our advocacy efforts, and using trade discussions when they're available. We'll try to make progress and address these issues as much as possible.